n,n-dimethylarginine has been researched along with Kidney Diseases in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 32 (52.46) | 29.6817 |
| 2010's | 27 (44.26) | 24.3611 |
| 2020's | 2 (3.28) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, D; Lee, Y; Singh, J; Steinbach, SML | 1 |
| Assaad, S; Chacra, D; Chelala, D; Fares, N; Hajal, J; Joubran, N; Saliba, Y; Sleilaty, G | 1 |
| Huang, D; Tan, B; Wang, C; Wang, Y; Wu, M; Ye, C; Yuan, M; Zou, Y | 1 |
| Cao, J; Lei, T; Liu, S; Lu, Z; Shi, L; Wang, H; Zhao, C | 1 |
| Abdullah, HI; Durdagi, S; Gulhan, MF; Sahna, E; Salmas, RE; Selamoglu, Z | 1 |
| Chen, XP; Hu, XL; Li, MP; Song, PY; Tang, J | 1 |
| Chen, D; Li, L; Lin, P; Luo, C; Wang, C; Wu, M; Xu, L; Yang, X; Ye, C; Zhang, Y; Zhou, B | 1 |
| Hsu, CN; Huang, LT; Lee, CT; Lee, WC; Lin, CY; Tain, YL | 1 |
| Akpek, M; Duran, M; Ergin, A; Günebakmaz, O; Karakaya, E; Kaya, MG; Tanrıkulu, E | 1 |
| Bode-Böger, SM; Fliser, D; Kielstein, JT; Schepers, E; Speer, T | 1 |
| Bilge, AK; Caliskan, Y; Deniz, G; Ozkok, A; Sariyar, M; Yildiz, A; Yilmaz, A; Yilmaz, BA | 1 |
| Alpoim, PN; Dusse, LM; Mota, AP; Rios, DR; Sousa, LP | 1 |
| Hidekazu, M; Ikee, R; Kobayashi, S; Maesato, K; Mano, T; Ohtake, T; Oka, M | 1 |
| Kiefte-de Jong, JC; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Guldener, C; van Ittersum, FJ | 1 |
| Kaida, Y; Matsumoto, Y; Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Getino, MA; Jarque, A; Lozano, L; Mora-Fernández, C; Navarro, JF; Sánchez, R | 1 |
| Kielstein, JT; Zoccali, C | 3 |
| Mallamaci, F; Zoccali, C | 1 |
| Blackwelder, WC; Hazen, SL; Kato, GJ; Machado, RF; Taylor, JG; Wang, Z | 1 |
| Fujiwara, N; Fukami, K; Kawagoe, Y; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Ueda, S; Ueda, Y; Yamagishi, S | 1 |
| Abedini, S; Fellstrøm, B; Holdaas, H; Holme, I; Jardine, A; März, W; Meinitzer, A; Weihrauch, G | 1 |
| Bode-Böger, SM; David, S; Fliser, D; Haller, H; Kielstein, JT; Kliem, V; Kümpers, P; Lukasz, A; Martens-Lobenhoffer, J | 1 |
| Axelsson, J; Caglar, K; Cayci, T; Eyileten, T; Kilic, S; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI | 1 |
| Caglar, K; Demirkaya, E; Eyileten, T; Kilic, S; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI; Zoccali, C | 1 |
| Chen, CC; Hsieh, CS; Huang, LT; Sheen, JM; Tain, YL; Wang, JY | 1 |
| Fliser, D; Kielstein, JT | 2 |
| Máñez, S; Marín, M | 1 |
| Asai, T; Blackwell, S; Dhaun, N; Goddard, J; Liebman, B; Lilitkarntakul, P; Melville, V; Pollock, J; Talwar, DK; Webb, DJ | 1 |
| Chung, MY; Hsu, CP; Lin, CC; Lin, SJ; Lu, TM | 1 |
| Barreto, DV; Barreto, FC; Eloot, S; Glorieux, G; Liabeuf, S; Massy, Z; Schepers, E; Vanholder, R | 1 |
| Bruno, RM; Ghiadoni, L; Grassi, G; Mancia, G; Seravalle, G; Tripepi, G; Zoccali, C | 1 |
| Baylis, C | 3 |
| Wilcox, CS | 1 |
| Celik, M; Celik, T; Iyisoy, A; Yaman, H; Yilmaz, MI; Yuksel, UC | 1 |
| Aldámiz-Echevarría, L; Andrade, F | 1 |
| Chien, SJ; Hsu, CN; Huang, CF; Huang, LT; Lin, YJ; Tain, YL | 1 |
| Bode-Böger, SM; Fliser, D; Haller, H; Kielstein, JT | 2 |
| Bode-Böger, SM; Fliser, D; Graf, S; Haller, H; Kielstein, JT; Klein, G | 1 |
| Abdulhayoglu, E; Barbato, D; Bustami, R; D'Alecy, LG; Desai, A; Handelman, GJ; Novak, JE; Rajagopalan, S; Saran, R; Warren, JS; Weitzel, W | 1 |
| Brodsky, SV; Chen, J; Goligorsky, MS; Li, H; O'Riordan, E; Smirnova, I | 1 |
| Bode-Böger, SM; Fliser, D; Haller, H; Kielstein, JT; Kronenberg, F; Morath, C; Ritz, E | 1 |
| Leiper, J; Vallance, P | 1 |
| Zoccali, C | 1 |
| Acikel, C; Aydin, A; Caglar, K; Cakir, E; Erbil, K; Eyileten, T; Genctoy, G; Ozcan, O; Ozgurtas, T; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yilmaz, MI; Zoccali, C | 1 |
| Acikel, C; Bilgi, C; Caglar, K; Cakir, E; Eyileten, T; Kaya, A; Oguz, Y; Oktenli, C; Sonmez, A; Vural, A; Yenicesu, M; Yilmaz, MI; Zoccali, C | 1 |
| Fukami, K; Imaizumi, T; Matsuguma, K; Matsumoto, Y; Matsuoka, H; Okuda, S; Shibata, R; Ueda, S; Yamagishi, S | 1 |
| Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
| Fukami, K; Matsumoto, Y; Okuda, S; Ueda, S; Yamagishi, SI | 1 |
| Lipman, ML; Mann, JF; Schiffrin, EL | 1 |
| Luo, Z; Onozato, ML; Palm, F; Wilcox, CS | 1 |
| Andreotti, F; Coluzzi, G; Marzo, F; Santucci, E | 1 |
| Andreotti, F; Coluzzi, G; Santucci, E | 1 |
| Axelsson, J; Carrero, JJ; Heimbürger, O; Lindholm, B; Massy, Z; Stenvinkel, P | 1 |
| Lentz, SR; Rodionov, RN | 1 |
| Fliser, D; Frölich, JC; Haller, H; Kielstein, JT | 1 |
24 review(s) available for n,n-dimethylarginine and Kidney Diseases
| Article | Year |
|---|---|
AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.
Topics: Animals; Arginine; Cardiovascular Diseases; Cardiovascular System; Humans; Kidney Diseases; Transaminases | 2017 |
Dimethylarginines ADMA and SDMA: the real water-soluble small toxins?
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Kidney Diseases; Water | 2014 |
Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease.
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Kidney Transplantation; Nitric Oxide; Nitric Oxide Synthase; Proteinuria | 2015 |
[Endothelial injury and CKD].
Topics: Animals; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Risk Factors | 2008 |
[Novelties in the field of progression factors in chronic kidney disease].
Topics: Adult; Amidohydrolases; Animals; Arginine; Carbon; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Disease Progression; Female; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Low Birth Weight; Infant, Newborn; Kidney Diseases; Male; Oxides; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Uremia; Uric Acid | 2008 |
Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Chronic Disease; Disease Progression; Genetic Therapy; Glomerular Filtration Rate; Growth Hormone; Humans; Kidney Diseases; Obesity; Risk Factors; Severity of Illness Index; Treatment Outcome | 2008 |
Pharmacological interventions on asymmetric dimethylarginine, a clinical marker of vascular disease.
Topics: Adrenergic Antagonists; Angiotensins; Arginine; Diabetes Complications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Kidney Diseases; Microcirculation; Nitric Oxide Synthase Type III; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Vascular Diseases | 2011 |
Nitric oxide synthase derangements and hypertension in kidney disease.
Topics: Amidohydrolases; Animals; Arginine; Chronic Disease; Disease Progression; Humans; Hypertension; Kidney; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase | 2012 |
Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Humans; Kidney Diseases; Rats; Reactive Oxygen Species; Risk Factors | 2012 |
Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
Topics: Adult; Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Child; Disease Progression; Endothelial Cells; Endothelium, Vascular; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Nitric Oxide; Oxidative Stress; Risk Factors | 2012 |
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Risk Factors | 2003 |
Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine?
Topics: Adult; Aged; Aging; Arginine; Enzyme Inhibitors; Humans; Kidney; Kidney Diseases | 2003 |
Endothelial cell dysfunction: the syndrome in making.
Topics: Animals; Apoptosis; Arginine; Cardiovascular Diseases; Cellular Senescence; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Hyperhomocysteinemia; Kidney Diseases; Models, Biological; Oxidative Stress; Syndrome | 2005 |
Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Endocrine System Diseases; Endothelium, Vascular; Haplorhini; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Rats; Rats, Inbred Dahl; Renal Dialysis; Risk Factors; Sodium Chloride, Dietary; Tunica Intima; Tunica Media; Uremia | 2005 |
Biomarkers in chronic kidney disease: utility and issues towards better understanding.
Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Chronic Disease; Disease Progression; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin T | 2005 |
Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
Topics: Absorption; Amidohydrolases; Arginine; Biological Availability; Cardiovascular Diseases; Chronic Disease; Comorbidity; Enzyme Inhibitors; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Genetic | 2006 |
The past, presence and future of ADMA in nephrology.
Topics: Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Kidney Diseases; Kidney Function Tests; Nitric Oxide Synthase; Risk Factors | 2007 |
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
Topics: Arginine; Citrulline; Dietary Supplements; Hepatocytes; Homocysteine; Humans; Kidney Diseases; Liver Diseases; Nitric Oxide Synthase; Obesity; Risk Factors; Vascular Diseases | 2007 |
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
Topics: Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarkers; Bone Resorption; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Disease Progression; Dogs; Dyslipidemias; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inflammation Mediators; Kidney Diseases; Oxidative Stress; Phosphates; Renin-Angiotensin System; Risk Factors | 2007 |
Nitric oxide deficiency in chronic kidney disease.
Topics: Arginine; Chronic Disease; Humans; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase | 2008 |
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Kidney; Kidney Diseases; Liver Diseases; Nitric Oxide; Nitric Oxide Synthase; Vasodilation | 2007 |
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Topics: Albuminuria; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Ossification, Heterotopic; Oxidative Stress; Risk Assessment; Uremia | 2008 |
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
Topics: Animals; Arginine; Arteriosclerosis; Enzyme Inhibitors; Humans; Kidney Diseases; Nitric Oxide Synthase | 2001 |
3 trial(s) available for n,n-dimethylarginine and Kidney Diseases
| Article | Year |
|---|---|
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Topics: Adult; Aged; Anticholesteremic Agents; Arginine; Carotid Arteries; Chronic Disease; Creatinine; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anticholesteremic Agents; Arginine; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Deoxyguanosine; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acid-Binding Proteins; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Middle Aged; Proteinuria; Quinolines; Severity of Illness Index; Treatment Outcome; Triglycerides | 2010 |
Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study.
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Arginine; Chronic Disease; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Oxidative Stress; Pilot Projects | 2003 |
34 other study(ies) available for n,n-dimethylarginine and Kidney Diseases
| Article | Year |
|---|---|
A Therapeutic Extracorporeal Device for Specific Removal of Pathologic Asymmetric Dimethylarginine from the Blood.
Topics: Animals; Arginine; Kidney Diseases; Swine | 2022 |
Intradialytic hypotension: beyond hemodynamics.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme 2; Arginine; Biomarkers; Blood Pressure; Endothelin-1; Endothelium, Vascular; Female; Humans; Hypotension; Kidney Diseases; Male; Membrane Glycoproteins; Middle Aged; Peptidyl-Dipeptidase A; Renal Dialysis; Renin; Time Factors; Vascular Endothelial Growth Factor C | 2019 |
Renal asymmetric dimethylarginine inhibits fibrosis.
Topics: Amidohydrolases; Animals; Arginine; Disease Models, Animal; Fibronectins; Fibrosis; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Renal Insufficiency, Chronic; Ureteral Obstruction | 2020 |
Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
Topics: Aging; Aldosterone; Amidohydrolases; Animals; Arginine; Cell Line; Creatinine; Diabetes Mellitus, Experimental; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Gene Knockout Techniques; Humans; Kidney Diseases; Kidney Tubules, Proximal; Mice | 2017 |
Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: An experimental and theoretical approach.
Topics: Animals; Antioxidants; Arginine; Aryldialkylphosphatase; Binding Sites; Caffeic Acids; Glutathione Reductase; Half-Life; Hypertension; Kidney Diseases; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Pollen; Propolis; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley | 2017 |
Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys.
Topics: Animals; Arginine; Cell Line; Gene Expression Regulation, Enzymologic; Humans; Kidney Diseases; Male; Mice; Nitric Oxide; Protein-Arginine N-Methyltransferases; Specific Pathogen-Free Organisms; Ureteral Obstruction | 2019 |
Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers.
Topics: Animals; Arginine; Blotting, Western; Electron Spin Resonance Spectroscopy; Female; Hypertension; Kidney Diseases; Pregnancy; Rats; Rats, Sprague-Dawley; Streptozocin | 2013 |
Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy.
Topics: Aged; Angina Pectoris; Arginine; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Predictive Value of Tests; ROC Curve | 2013 |
Cardiovascular-renal changes after kidney donation: one-year follow-up study.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Interleukin-6; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Nephrectomy; Prospective Studies; Risk Factors; Time Factors; Tissue Donors; Treatment Outcome; Uric Acid; Vascular Cell Adhesion Molecule-1; Vasodilation; Young Adult | 2015 |
Coronary artery calcification, ADMA, and insulin resistance in CKD patients.
Topics: Aged; Arginine; Calcinosis; Case-Control Studies; Chronic Disease; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Insulin Resistance; Kidney Diseases; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed | 2008 |
Clinical implications of elevated asymmetric dimethylarginine in chronic kidney disease and end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Carotid Arteries; Humans; Kidney Diseases; Kidney Failure, Chronic; Risk Factors; Uremia | 2009 |
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
Topics: Anemia, Sickle Cell; Arginine; Case-Control Studies; Citrulline; Follow-Up Studies; Hemolysis; Humans; Hypertension, Pulmonary; Kidney Diseases; Linear Models; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Proportional Hazards Models; Risk; Survival Rate | 2009 |
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.
Topics: Adult; Arginine; Cardiovascular Diseases; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Middle Aged; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2010 |
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
Topics: Adult; Aged; Angiopoietin-2; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chronic Disease; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Nephrectomy; Risk Factors; Tissue Donors | 2010 |
Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Chronic Disease; Diabetic Nephropathies; fas Receptor; Female; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Myostatin; Proteinuria; Ramipril | 2010 |
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.
Topics: Adult; Arginine; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forearm; Humans; Kidney Diseases; Linear Models; Male; Middle Aged; Multivariate Analysis; Nitric Oxide; Risk Factors; Vasodilation | 2010 |
Bile duct ligation in developing rats: temporal progression of liver, kidney, and brain damage.
Topics: Animals; Arginine; Bile Ducts; Brain; Brain Diseases; Cholestasis; Disease Progression; End Stage Liver Disease; Kidney; Kidney Diseases; Laparotomy; Ligation; Lipocalins; Liver; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Time Factors | 2010 |
Do sea stars have low ADMA levels? High ADMA and low EPC count--duo infernal for the kidney.
Topics: Animals; Arginine; Cell Count; Chronic Disease; Endothelial Cells; Glomerular Filtration Rate; Humans; Kidney Diseases; Stem Cells | 2010 |
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.
Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Case-Control Studies; Chronic Disease; Comorbidity; Compliance; Cross-Sectional Studies; Disease Progression; Endothelin-1; Endothelium, Vascular; Female; Femoral Artery; Glomerular Filtration Rate; Humans; Isoprostanes; Kidney; Kidney Diseases; Linear Models; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Pulsatile Flow; Risk Assessment; Risk Factors; Scotland; Uremia; Vasodilation | 2011 |
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Disease-Free Survival; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Taiwan; Time Factors | 2011 |
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Arginine; Belgium; Biomarkers; Case-Control Studies; Cell Line; Chronic Disease; Cross-Sectional Studies; Female; Humans; Inflammation Mediators; Interleukin-6; Kidney Diseases; Linear Models; Male; Middle Aged; Monocytes; NF-kappa B; Predictive Value of Tests; ROC Curve; Tumor Necrosis Factor-alpha | 2011 |
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chronic Disease; Cross-Sectional Studies; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypertrophy, Left Ventricular; Italy; Kidney; Kidney Diseases; Linear Models; Male; Proteinuria; Risk Assessment; Risk Factors; Severity of Illness Index; Sympathetic Fibers, Postganglionic; Ventricular Remodeling | 2011 |
The relationship between L-arginine/ADMA ratio and coronary collateral development in patients with low glomerular filtration rate.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Chi-Square Distribution; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neovascularization, Physiologic; Odds Ratio; Risk Assessment; Risk Factors; Severity of Illness Index; Turkey | 2012 |
Aminoguanidine attenuates hypertension, whereas 7-nitroindazole exacerbates kidney damage in spontaneously hypertensive rats: the role of nitric oxide.
Topics: Amidohydrolases; Animals; Arginine; Blood Pressure; Citrulline; Guanidines; Hypertension; Indazoles; Kidney Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Rats, Inbred SHR; Sodium Chloride, Dietary; Up-Regulation | 2013 |
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure.
Topics: Aged; Arginine; Endothelium, Vascular; Heart Failure; Humans; Kidney Diseases; Male; Renal Circulation; Vasodilation | 2003 |
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study.
Topics: Adult; Arginine; Creatinine; Disease Progression; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide; Parathyroid Hormone; Proportional Hazards Models; Renal Insufficiency; Treatment Outcome | 2005 |
Asymmetric dimethylarginine and kidney disease--marker or mediator?
Topics: Animals; Arginine; Biomarkers; Humans; Kidney; Kidney Diseases; Nitric Oxide; Renal Insufficiency; Risk | 2005 |
The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
Topics: Adult; Arginine; Brachial Artery; Cardiovascular Diseases; Chronic Disease; Copper; Endothelium, Vascular; Erythrocytes; Female; Glomerular Filtration Rate; Glutathione Peroxidase; Humans; Kidney Diseases; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Selenium; Severity of Illness Index; Superoxide Dismutase; Vasodilation; Zinc | 2006 |
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Chronic Disease; Disease Progression; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Kidney Diseases; Male; Proteinuria; Regression Analysis | 2006 |
Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
Topics: Amidohydrolases; Animals; Arginine; Capillaries; Chronic Disease; Disease Models, Animal; Disease Progression; Fibrosis; Gene Expression Regulation, Enzymologic; Genetic Therapy; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
A new perspective for the treatment of renal diseases?
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Chronic Disease; Humans; Kidney Diseases; Nitric Oxide Synthase; Risk Factors | 2007 |
Asymmetric dimethylarginine and impaired cardiovascular healing.
Topics: Apoptosis; Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Myocardial Ischemia; Nitric Oxide; Prognosis; Regeneration; Stem Cells; Treatment Outcome | 2009 |
Contrast-induced nephropathy and mortality: possible crucial role of asymmetric dimethylarginine.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Antioxidants; Arginine; Biomarkers; Contrast Media; Coronary Angiography; Humans; Kidney Diseases; Nitric Oxide | 2007 |
The homocysteine paradox.
Topics: Animals; Arginine; Cardiovascular Diseases; Cystatin C; Cystatins; Disease Models, Animal; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Risk Factors; Vitamin B 12; Vitamin B 6 | 2008 |